You also obtained the MIC for a variety of common antifungals by testing them against a single strain of Aspergillus fumigatis. Six replicates of each were tested. MIC (ug/mL) Amphotericin B 1 Miconazole 0.06 Ciclopirox 0.01 Nystatin 0.625 New product 0.1 Two-way ANOVA Amp v. New 3.70E-04 Nys v. New 4.16E-05 Mico v. New 0.04 Cic vs. New 1.50E-05 Additionally, Candida aurus is a fungus that is rapidly becoming resistant to multiple antifungals. Because strains now exist that are completely resistant to three or more families of antifungals, there is room in the market for an antifungal that is effective against C. aurus. If the data above is representative for the efficacy against both A. fumigatus, a fungus that is plentiful and sensitive to most antifungals, and C. aurus, determine whether this efficacy data supports room for this product on the existing marketplace. If you think more data is required in order to make a final decision about this product, please elaborate on the required experiments. NOTE: There is no missing information. This is all that is given. NOTE:PLEASE GIVE THE ANSWER WITH IN 2 HOURS.THANK YOU
You also obtained the MIC for a variety of common antifungals by testing them against a single strain of Aspergillus fumigatis. Six replicates of each were tested.
| MIC (ug/mL) | |
|---|---|
| Amphotericin B | 1 |
| Miconazole | 0.06 |
| Ciclopirox | 0.01 |
| Nystatin | 0.625 |
| New product | 0.1 |
| Two-way ANOVA | |
|---|---|
| Amp v. New | 3.70E-04 |
| Nys v. New | 4.16E-05 |
| Mico v. New | 0.04 |
| Cic vs. New | 1.50E-05 |
Additionally, Candida aurus is a
NOTE: There is no missing information. This is all that is given.
NOTE:PLEASE GIVE THE ANSWER WITH IN 2 HOURS.THANK YOU
Step by step
Solved in 3 steps
